{"url_path":"/sec/auph/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1600620/0001600620-26-000053-index.html","accession_number":"0001600620-26-000053","cik":"0001600620","ticker":"AUPH","issuer_name":"Aurinia Pharmaceuticals Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1600620/0001600620-26-000053-index.html","primary_entity_key":"0001600620","primary_entity_name":"Aurinia Pharmaceuticals Inc."},"word_count":80,"has_tables":true,"body_markdown":"Item 9.01Financial Statements and Exhibits\n\n(d) Exhibits.\n\nExhibit No.Description\n\n104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: June 4, 2026\n\nAURINIA PHARMACEUTICALS INC.\n\nBy:/s/ Stephen P. Robertson\n\nName:Stephen P. Robertson\n\nTitle:Chief Legal Officer, Corporate Secretary and Chief Compliance Officer"}